全文获取类型
收费全文 | 5395篇 |
免费 | 351篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 230篇 |
妇产科学 | 209篇 |
基础医学 | 692篇 |
口腔科学 | 96篇 |
临床医学 | 505篇 |
内科学 | 1142篇 |
皮肤病学 | 51篇 |
神经病学 | 271篇 |
特种医学 | 645篇 |
外国民族医学 | 1篇 |
外科学 | 689篇 |
综合类 | 50篇 |
一般理论 | 2篇 |
预防医学 | 323篇 |
眼科学 | 33篇 |
药学 | 357篇 |
中国医学 | 4篇 |
肿瘤学 | 447篇 |
出版年
2021年 | 44篇 |
2020年 | 36篇 |
2019年 | 46篇 |
2018年 | 65篇 |
2017年 | 57篇 |
2016年 | 77篇 |
2015年 | 98篇 |
2014年 | 111篇 |
2013年 | 158篇 |
2012年 | 196篇 |
2011年 | 210篇 |
2010年 | 186篇 |
2009年 | 140篇 |
2008年 | 165篇 |
2007年 | 187篇 |
2006年 | 162篇 |
2005年 | 205篇 |
2004年 | 183篇 |
2003年 | 174篇 |
2002年 | 162篇 |
2001年 | 153篇 |
2000年 | 154篇 |
1999年 | 133篇 |
1998年 | 181篇 |
1997年 | 158篇 |
1996年 | 166篇 |
1995年 | 135篇 |
1994年 | 103篇 |
1993年 | 114篇 |
1992年 | 115篇 |
1991年 | 99篇 |
1990年 | 97篇 |
1989年 | 145篇 |
1988年 | 128篇 |
1987年 | 119篇 |
1986年 | 107篇 |
1985年 | 126篇 |
1984年 | 58篇 |
1983年 | 63篇 |
1982年 | 60篇 |
1981年 | 45篇 |
1980年 | 54篇 |
1979年 | 47篇 |
1978年 | 47篇 |
1977年 | 48篇 |
1976年 | 42篇 |
1975年 | 53篇 |
1973年 | 47篇 |
1971年 | 30篇 |
1966年 | 30篇 |
排序方式: 共有5770条查询结果,搜索用时 31 毫秒
81.
82.
83.
A. Brunner Uehlinger W. Kyrieleis H. E. Bock Niessing H. W. Altmann O. Fischer Plückthun A. Kühn H. Kalk E. Wollheim R. Zenker K. Burger R. Mittermaier Zinser de Rudder Engelking 《Journal of molecular medicine (Berlin, Germany)》1956,34(7-8):212-219
Ohne Zusammenfassung 相似文献
84.
Gsell Bargmann H. Kranz K. Burger 《Journal of molecular medicine (Berlin, Germany)》1956,34(13-14):402-404
85.
Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease 总被引:2,自引:0,他引:2
Vuilleumier N Reber G James R Burger D de Moerloose P Dayer JM Roux-Lombard P 《Journal of autoimmunity》2004,23(4):227-360
Anti-apolipoprotein A-1 (Apo A-1) autoantibodies were described in autoimmune disorders such as systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) and might be involved in the genesis of arterial and venous thrombotic events. To investigate the presence of these autoantibodies in patients with acute coronary syndrome (ACS) without other features of autoimmunity, we set up an enzyme-linked immunosorbent assay (ELISA) for anti-Apo A-1 antibodies. We used it to investigate their prevalence in ACS as compared to SLE and APS and correlated them to plasma Apo A-1 and serum amyloid A protein (SAA) concentrations. The prevalence of anti-Apo A-1 autoantibodies in the healthy control group was 1% (1/92), but was significantly higher in other groups: 21% (11/53) in ACS group (P=0.001), 13% (12/92) in SLE and/or APS group (P=0.005). Multiple linear regression revealed a significant correlation between plasma Apo A-1 (r=-0.72, P=0.013), plasma SAA concentration (r=0.76, P=0.0066) and anti-Apo A-1 IgG titre in ACS patients. The presence of anti-Apo A-1 autoantibodies in patients with ACS highlights an additional link between autoimmunity, inflammation and atherosclerosis. 相似文献
86.
Successful outcome with day 4 embryo transfer after preimplantation diagnosis for genetically transmitted diseases 总被引:4,自引:5,他引:4
Preimplantation genetic diagnosis was performed in 61 day 3 embryos
obtained by in-vitro fertilization from seven patient carriers of
haemophilia, Marfan's syndrome, Bloch-Sulzemberg syndrome (incontinentia
pigmentosa) or X chromosome-linked immune deficiency, retinitis pigmentosa,
and FG syndrome, which is characterized by mental retardation and
hypotonia. After multiplex polymerase chain reaction, 16 embryos were
diagnosed as being unaffected, and these were transferred to the uterus on
the following day (day 4). Of these embryos, six (37.5%) implanted,
resulting in the delivery of a singleton and a twin pregnancy, a late
second trimester miscarriage (twins at week 20) and a first trimester
miscarriage at week 8. All the diagnoses were confirmed by amniocentesis.
We report for the first time a late day 4 transfer of biopsied human
embryos undergoing preimplantation genetic diagnosis. This transfer
schedule allows an extra day to perform genetic analyses on single
blastomeres and to monitor any adverse effect of the biopsy procedure.
相似文献
87.
88.
89.
How to use Chlamydia antibody testing in subfertility patients 总被引:1,自引:9,他引:1
Screening for tubal factor subfertility by means of Chlamydia antibody
testing (CAT) was introduced into the initial work-up of subfertile couples
several years ago. The results reported, however, are heterogeneous, and no
uniformity exists in cut-off levels of titres, or in definitions of tubal
factor subfertility. We performed a prospective cohort study to evaluate
the implications of varying the definitions of tubal pathology and of
modifying the cut-off levels on the clinical impact of CAT in predicting
tubal factor subfertility. In 227 consecutive patients who attended our
fertility clinic, the Chlamydia IgG antibody titre was determined and
related to tuboperitoneal abnormalities at laparoscopy as a reference
standard. According to received operating characteristic (ROC) curve
analysis, a titre of 16 is the optimum cut-off level. Increasing the
cut-off level improves specificity and positive likelihood ratio (LR+), at
the expense of sensitivity and negative LR (LR-). Changing the definition
of tubal factor subfertility from unspecified tuboperitoneal abnormalities
into extensive adhesions and/or bilateral distal tubal occlusion improves
LR+, LR- and kappa significantly. We conclude that CAT is more accurate in
predicting severe distal tubal pathology than unspecified tuboperitoneal
abnormalities. Although from a statistical point of view a titre of 16 is
the optimum cut-off level, from a clinical point of view 32 or 64 may be
preferable, depending on the aim of screening and the inception cohort.
相似文献
90.
Anxiety during pregnancy and fetal attachment after in-vitro fertilization conception 总被引:3,自引:4,他引:3
McMahon CA; Ungerer JA; Beaurepaire J; Tennant C; Saunders D 《Human reproduction (Oxford, England)》1997,12(1):176-182
The aim of this study was to compare 70 couples who had conceived by in-
vitro fertilization (IVF) with 63 matched controls for the prevalence of
anxiety and quality of attachment to the baby during pregnancy. Results for
mothers showed no group differences using a global measure of anxiety, the
Spielberger State-Trait Anxiety Inventory. However, pregnancy-specific
measures revealed significantly higher levels of anxiety in IVF mothers
about the survival and normality of their unborn babies, about damage to
their babies during childbirth and about separating from their babies after
birth. When IVF mothers were differentiated according to the number of
treatment cycles, more differences in anxiety level were revealed, with
most increases occurring in mothers who had experienced two or more
treatment cycles. IVF fathers did not differ from controls on the global
anxiety measure. No data on pregnancy-specific anxiety were available for
fathers. Neither IVF mothers nor IVF fathers differed from controls on
measures of attachment to the baby during pregnancy. Results are discussed
in the context of the need for researchers to employ differentiated and
issue-specific measures to identify concerns that may be unique to IVF
couples. Clinical implications regarding the need for psychological support
during pregnancy are also discussed.
相似文献